Abstract
The incidence of chronic granulomatous disease in international reports is 1:250,000; however, in Mexico it is unknown. At the National Institute of Pediatrics of Mexico a project for facilitating the diagnosis of the disease was implemented by us in 2009. From the start of such project up to date 68 cases have been studied; 80% of those are X-linked forms (LX) and moreover, it has become noticeable the diagnosis at a younger age. The new challenge we are facing its to provide a successful treatment to those patients diagnosed with chronic granulomatous disease (CGD). We are reporting the case of a one-month old newborn patient diagnosed with CGD-LX that was successfully transplanted in Mexico.References
Roos D, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis 2010;44:291-299.
Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol 2008;28(Suppl 1):S67-72. 3. Winkelstein JA, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155-169.
Berron-Ruiz L, et al. Detection of inheritance pattern in thirty-three Mexican males with chronic granulomatous disease through 123 dihydrorhodamine assay. Allergol Immunopathol (Madr) 2014;42:580-585.
van den Berg JM, et al. Chronic granulomatous disease: the European experience. PLoS One 2009;4:5234.
González A. Características clinicas y moleculares de pacientes mexicanos con enfermedad granulomatosa crónica diagnosticados durante los últimos 10 años. 2015, Facultad de Medicina. División de estudios de posgrado e investigación UNAM, 1-44.
de Oliveira-Junior EB, et al. Clinical and genotypic spectrum of chronic granulomatous disease in 71 Latin American patients: First report from the LASID registry. Pediatr Blood Cancer 2015.
Gungor T, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet 2014;383:436-448.
Martinez CA, et al. Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease. J Allergy Clin Immunol 2012;129:176- 183.
Soncini E, et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. Br J Haematol 2009;145:73-83.
Klaudel-Dreszler MA, et al. Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC. Int J Hematol 2009;90:571-575.
Cole T, et al. Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Immunol 2013;132:1150-1155.
Prasad VK. Stem-cell transplantation for chronic granulomatous disease. Lancet 2014;383:390-392.
Cole T, et al. Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant. J Clin Immunol 2013;33:8-13.
Jones LB, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol 2008;152:211-218.
Kim HY, et al. Rapid determination of chimerism status using dihydrorhodamine assay in a patient with X-linked chronic granulomatous disease following hematopoietic stem cell transplantation. Ann Lab Med 2013;33:288-292.
Gonzalez-Ortiz A. Características clínicas y moleculares de pacientes mexicanos con enfermedad granulomatosa crónica diagnosticados durante los últimos 10 años. División de Posgrado e Investigación. México: UNAM, 2015.
Notarangelo LD. The long road to optimal management for chronic granulomatous disease. J Allergy Clin Immunol 2013;132:1164-1165.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2016 Revista Alergia México